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ABSTRACT 
The objective of the study was to enhance the solubility and dissolution rate of Tadalafil using hydrophilic carriers such as polyvinyl 
pyrrolidone K-30 (PVP), Poloxamer 188, Sodium starch glycolate and compatibility study of Tadalafil with different polymers by 
FTIR. Characterization of solid dispersion-FTIR, DSC and phase solubility analysis was study to improve the oral bioavailability. 
Formulation and evaluation of immediate release tablets prepare from solubility enhanced Tadalafil. Among the various approaches 
Solvent evaporation has gained good acceptance in recent years in the industry for enhancing the solubility and dissolution rate of 
poorly soluble drugs. Poloxamer 188 used as polymer as it is good solubilizing agent. As per the phase solubility studies, a 32 
factorial study were used to prepare the immediate release tablet and evaluated for the interactions and in vitro drug release. Sodium 
Starch Glycolate and PVP used as superdisintegrants. The solubility of tadalafil in selected ratios containing tadalafil and Poloxamer 
188 solid dispersion prepared by solvent evaporation was determined. From the various ratios 1:0.5 was resulted in a much higher 
enhancement (9.75folds). Fourier transform infrared spectroscopy (FT-IR) and differential scanning calorimetry (DSC) studies 
conducted, explain overall drug and excipients compatibility. More than 90% of tadalafil was released from IR tablet within 30 min. 
There is enhancement of the solubility rate if tadalafil by solid dispersion with Poloxamer 188 prepared by solvent evaporation 
method. The drug was characterized for its organoleptic properties and the results obtained. The compatibility studies of the drug and 
polymers showed that there was no incompatibility between them. Wet granulation method showed that, the desirable flow 
properties for the compression into tablets. Tablets were prepared using wet granulation method resulted into simple, cheap, more 
suitable method for the manufacturing immediate release dosage form.  
Keywords: Immediate release tablet, Superdisintigrants, Wet granulation method, Poloxamer 188. 
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INTRODUCTION 
Hypertension or high blood pressure (BP) is a medical 
condition, in which the BP in the arteries is persistently 
elevated. BP is the force of blood pushing up against the 
wall of blood vessels (arteries and veins). Important 
organs affected are heart leading to heart attack or heart 
failure, brain leading to stroke, kidney leading to 
chronic renal failure, eyes leading to bleeding in retina, 
loss of vision, and nerve damage
1
.  WHO rates the 
hypertension as one of the most important causes of 
premature death in worldwide. According to the WHO 
hypertension is a highly prevalent cardiovascular 
disease. In India, hypertension is the most prevalent 
chronic disease. The prevalence of hypertension ranges 
from 20% to 40% in urban adults and 12-17% among 
rural adults
2
. Oral route is most common route of 
administration of drug because of its systemic effect, 
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patient compliance, less expensive to manufacture. 
Tablet provides high precision dosing. In most of the 
cases immediate on set of action is required as compare 
to conventional therapy. To achieve the rapid onset of 
action and eliminate the drawbacks of conventional 
therapy immediate release dosage form is now a days 
popular oral dosage form. Basic approach used in 
development is the use of superdisintegrants which 
provide rapid disintegration of tablet after 
administration
3
. This research work is concerned with 
the formulation and evaluation of immediate release 
tablet of Tadalafil to provide immediate relief from 
hypertension. A solubility and dissolution are the key 
parameters for the therapeutic effect of a drug. 
Solubility is one of the important parameter to achieve 
desire concentration of drug in systemic circulation for 
pharmacological response
4
.  
More than 92% of the drug listed in U.S. pharmacopoeia 
which is having low solubility. It is commonly 
recognized in the pharmaceutical industry that on 
average more than 40% of newly discovered drug 
candidates are having poor solubility. Micronization, 
Nanonization, salt formation, use of surfactants, solid 
dispersion are the several methods for enhancement of 
solubility of the drugs 
5,6,7
. Solid dispersion techniques 
can be used to increase dissolution and absorption of 
several insoluble drugs
8,9
. To date, a number of drugs 
are not showing complete therapeutic effect because of 
their poor solubility and dissolution, which in turn leads 
to poor bioavailability of the drug
10,11
. So, in the modern 
days, top most importance is given for increasing the 
dissolution rate of poorly soluble drugs, which enhances 
their bioavailability. Solid dispersions are one of the 
most promising strategies to improve the solubility and 
dissolution rate of poorly water-soluble drugs
12
. By 
reducing the drug particle size to the absolute minimum, 
and hence, thereby improving drug wettability, 
bioavailability may can be significantly improved. They 
are usually presented as amorphous products the term 
"'solid dispersion'" has been utilized to describe a family 
of dosage forms, whereby the drug is dispersed in a 
biological inert matrix, usually with a view in order to 
enhancing the oral bioavailability. More specifically, 
Chiou and Regelman (1971), defined these systems as 
"the dispersion of one or more active ingredient in an 
inert matrix at solid-state prepared by the melting 
(Fusion), solvent or melting solvent method"
13,14
. 
Tadalafil is an inhibitor of phosphodiesterase 5 (PDE-5), 
the enzyme responsible for the degradation of cyclic 
guanosine monophosphate (cGMP). PAH is associated 
with the impaired release of nitric oxide by the vascular 
endothelium in the pulmonary vasculature. Inhibition of 
PDE-5 by tadalafil increases the concentrations of 
cGMP, resulting in relaxation of pulmonary vascular 
smooth muscle cells and vasodilation of the pulmonary 
vascular bed. Tadalafil is a white or almost white 
powder and it is poorly soluble in water. Since the 
dissolution rate of the drug from surface is affected by 
the carrier has an ultimate influence on the dissolution 
of the dispersed drug. Hence hydrophilic carrier 
polaxmer188 was used as carriers for converting 
Tadalafil into solid dispersions in this study. 
MATERIAL AND METHOD 
Tadalafil was obtained as gift sample from Cipla 
Pharmaceutical, Ltd, Mumbai. Polaxmer-188 from 
Glenmark Pharmaceutics, Sinnar Nashik, methanol from 
Research-Lab Fine Chem. Industry, Mumbai, PVP and 
Sodium starch glycolate from Research-Lab Fine Chem. 
Industry–Mumbai. lactose, microcrystalline cellulose, 
Magnesium stearate, talc from Research-Lab Fine 
Chem. Industry–Mumbai. 
Preformulation Study of Drug: 
Preformulation testing is the first step in the rational 
development of dosage forms of a drug. It can be 
defined as an investigation of physical and chemical 
properties of drug substance, alone and when combined 
with excipients. The overall objective of preformulation 
testing is to generate information useful to the 
formulator in developing stable and bioavailable dosage 
forms, which can be mass-produced
15, 16
. 
Identification Tests 
Organoleptic Properties: 
The sample of Tadalafil was studied for organoleptic 
characteristics such as colour, odour and appearance. 
Melting Point: 
Melting point of Tadalafil was determined by taking a 
small amount of sample in a capillary tube closed at one 
end and placed in melting point apparatus. The melting 
point was noted in triplicate and average value was 
noted
17
. 
IR Spectroscopy 
The FT-IR spectrum of the obtained sample of drug was 
compared with the standard FT-IR spectra of the pure 
drug. 
Solubility
:
 The solubility of Tadalafil was checked in 
different solvents: water, methanol, ethanol, 0.1 N HCl, 
0.1 N NaOH, and phosphate buffer 6.9. mL of   was 
added to 10 mg of Tadalafil separately and shaken 
vigorously for 5 minute and placed in a constant 
temperature bath for 15minutes
18
. 
Differential Scanning Calorimetry: Differential 
Scanning Calorimetry (DSC) was performed using 
differential scanning calorimeter (SW9.2, Mettler Star) 
equipped with a computerized data station on pure drug 
tadalafil to determine the melting point and exothermic 
and endothermic peaks. An empty standard aluminium 
pan was used as reference. DSC scans were recorded at 
heating rate of 10°C/min in the temperature range30°-
300°C and 40 ml/min of nitrogen flow. 
Ultraviolet-Visible Spectroscopy: The UV spectrum of 
Tadalafil was obtained using UV Visible Double Beam 
Spectrophotometer (V630, Jasco). Accurately weighed 
10 mg of the drug was dissolved separately in solvent 
(methanol) volume was made up to 100mL by the 
respective solvent to obtain a stock solution of final 
concentration 100 μg/mL. Aliquot (1mL) of stock 
solution of Tadalafil was transferred into a series 10mL 
volumetric flask and volume was made up to the mark 
with the respective solvent to produce the concentration 
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range 10 μg/mL. The resultant solution was scanned 
from 200 to 400 nm and the spectrum was recorded to 
obtain the value of maximum wavelength. The stock 
solution of 100μg/mL was used to prepare different 
dilutions in the range of 2-20μg/mL. The absorbance 
values for resulting solutions were measured at λmax 
using respective solvent as blank by UV-visible 
spectrophotometer
19
. 
Compatibility Study: 
Physicochemical compatibility study: Compatibility 
study of drug and polymers was done in vials for 1-
month at40⁰ C. The drug to polymer ratio was taken as 
1:0.5, 1:1 and 1:2. The vials were daily checked for gas 
formation, colour change, liquefaction and caking by 
visual inspection and results were noted down. 
Preparation of solid dispersions of Tadalafil: Solid 
dispersions were prepared by solvent evaporation 
technique. Physical mixtures of Tadalafil were 
prepared by mixing Tadalafil and polaxomer188 in 
sufficient amount of methanol individually in a glass 
mortar by trituration for 30 minutes. 
Table 1: Composition of various Solid dispersion 
S.N. Composition of Drug 
polymer 
Ratios (w/w) 
1 
2 
3 
Tadalafil: Poloxamer 188 
Tadalafil: Poloxamer 188 
Tadalafil: Poloxamer 188 
1:0.5 
1:1 
1:2 
 
Evaluation of prepared Solid Dispersions: 
Production yield: The production yield formulation 
was calculated using the weight of final product after 
drying with respect to the initial total weight of the drug 
and carrier used for the preparation of complex.  
Drug content:  
About 10 mg drug equivalent were weighed accurately 
and transferred to 100 ml volumetric flask. From this 
stock solution (100μg/ml), 1 ml was withdrawn and 
further diluted upto 10 ml with methanol. This solution 
was used for the assay for drug content by UV 
spectrophotometer at 284 nm. Concentration of drug in 
stock solution was calculated by using calibration curve 
and from which percentage drug content in complex was 
calculated. 
 
Fourier Transform Infrared Spectroscopy 
Compatibility study was carried out by using Fourier 
transform infrared spectrophotometer. FTIR study was 
carried on pure drug and solid dispersion (SD). SD was 
prepared, and samples were stored at 400C for 1month. 
The infrared absorption spectrum of drug and SD of 
drug was recorded with a KBr disc over the wave 
number 4000 to 400 
cm-1
. 
Differential Scanning Calrimetry (DSC): 
Thermal analysis was performed using a differential 
scanning calorimeter equipped with a computerized data 
station. The sample of pure drug and SD of drug was 
weighed and heated at a scanning rate of 10°C/min 
between 30°C and 300°C and 40ml/min of nitrogen 
flow. DSC analysis gives an idea about the interaction 
of various materials at different temperatures. It also 
allows detecting possibility degradation of the material. 
X ray Diffraction:  
For the structural, crystal, and physical state 
characterization of Tadalafil, X-Ray diffraction studies 
were performed for pure drug, Tadalafil. XRD study 
was carried out with Bruker AXS D8 Advance with 
Vertical, Theta/2 geometry using copper target, a 
voltage of 40 kv and a current of 35 mA. The scanning 
was done over 2θ range of 3º to 135º. 
Formulation and Development of Tablet of solid 
dispersion    
Method of preparation of Granules: Tadalafil 
dispersions were taken in mortar and pestle along with 
suitable diluents and mixed constantly until a dry is mix 
obtained (before mixing both the diluents and 
dispersions were allowed to pass through # 22 mesh). 
The binder was dissolved in hot purified water and 
stirred constantly until the complete PVP goes into 
solution. Binder solution was added to above dry mix 
and mixed slowly. Extra water was added till required 
consistency of mass is obtained and sifted through #22 
mesh to obtain granules. Granules were dried in hot air 
oven and sifted through #24 to obtain uniform sized 
granules. The sifted granules were taken and blended 
with Talc and disintegrant for 10 min. Magnesium 
stearate was sifted and added to above blend and 
lubricated for 5 mins. The blend was compressed into 
tablet using punches and suitable dies with a tablet 
weight of 250 mg. 
 
Table 2: Composition of formulations as per 3
2
 full factorial design 
Formulation Code F1 F2 F3 F4 F5 F6 F7 F8 F9 
Ingredient Mg 
SD  
CCS 
SSG 
PVP 
Magnesium Stearate 
MCC 
Lactose 
Talc 
28 
7.5 
5 
7.5 
10 
50 
  141 
1 
28 
10 
5 
7.5 
10 
50 
138.5 
1 
28 
12.5 
5 
7.5 
10 
50 
136 
1 
28 
7.5 
12.5 
7.5 
10 
50 
133.5 
1 
28 
10 
12.5 
7.5 
10 
50 
131 
1 
28 
12.5 
12.5 
7.5 
10 
50 
128.5 
1 
28 
7.5 
20 
7.5 
10 
50 
126 
1 
28 
10 
20 
7.5 
10 
50 
123 
1 
28 
12.5 
20 
7.5 
10 
50 
121 
1 
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Evaluation of Granules: The flow properties of 
granules (before compression) were characterized in 
terms of angle of repose, tapped density, bulk density, 
Carr’s index and Hausner’s ratio. 
Formulation of Tadalafil Tablets: Tablets each 
containing 20mg of TD were formulated employing TD 
co-evaporate of polaxmer188 (1:0.5) along with the 
usual tablet excipients. The formula of TD tablets is 
given in Table 2. TD tablets were prepared by 
conventional wet granulation method. 
Evaluation of Tablet: 
Thickness: The thickness of tablet is important for 
uniformity of tablet size. The thickness of the tablets 
was determined using a Digital Vernier Calliper. Three 
tablets from each batch were used. 
Hardness: For each formulation, the hardness of three 
tablets was checked using the Monsanto hardness tester 
(LAB- HOSP). 
Friability: Friability is the measure of tablet strength. In 
this test, number of tablets subjected to combined effect 
of shock abrasion by utilizing a plastic chamber which 
revolves at a speed of 25rpm, dropping the tablets at a 
distance of 6 inches in each revolution. A sample of pre-
weighed tablets was placed in Roche Friability tester 
(Kumar Mfg. Ltd.). This was then operated for 100 
revolutions. The tablets then de-dusted and reweighed. 
Permitted friability limit is 1.0%. Tablets were then 
weighed, and friability values were determined. 
Uniformity of weight: Twenty tablets were weighed 
individually. Average weight was calculated from the 
total weight of all tablets. The individual weights were 
compared with the average weight. The percentage 
difference in the weight variation should be within the 
acceptable limits (5%). The percent deviation was 
calculated using the following formula. 
Drug content uniformity: Five tablets were weighed 
individually and powdered. The powder equivalent to 20 
mg of tadalafil was weighed and dissolved in methanol. 
The volume was made to 100 with methanol. From this 
stock solution, 10 μg/ml solution was prepared. The 
drug contents of the resulting solution were calculated 
from UV absorbance at 284.0 nm. 
Disintegration time: The in-vitro disintegration studies 
were carried out using Tablet Disintegration Test 
apparatus. One tablet was placed in each of the six tubes 
of the basket assembly and disk was added to each tube. 
This assembly was then suspended in one-liter beaker 
containing water maintained at 37±2
0
C. The basket was 
then moved up and down through a distance of 5 to 6 cm 
at a frequency of 28 to 32 cycles per minutes. The time 
required for complete disintegration of the tablet was 
recorded. The test was performed for tablets of all type 
of formulation (F1-F9).  
In-Vitro drug release study: An in-vitro drug release 
studies of the prepared nine formulations of 
Conventional tablet were conducted for a period of 60 
minutes using an eight station USP type 2 apparatus 
(paddle type). The agitation speed was 50 rpm. Tadalafil 
tablet were added to 900 ml of 0.1N HCL at 37 ± 0.5° C. 
5 ml aliquots were withdrawn at time intervals of 5, 10, 
15, 20, 25, 30 min and filtered through Whatmans filter 
paper. An equal volume of fresh dissolution medium 
was replaced to maintain the volume of dissolution 
medium. The filtered samples were analysed 
spectrophotometrically at 284.0 nm. Cumulative 
percentage of labelled amount of drug released was 
calculated. 
Stability study: The optimized formulation was 
wrapped in aluminium foil and subjected to 40 ±2°C 
temperature and 75± 5% RH in oven for the period of 
three months. The formulation was analyzed for 
organoleptic characteristics, thickness, hardness, drug-
content, disintegration time, weight variation and 
dissolution. In any rational design and evaluation of 
dosage forms for drugs, the stability of the active 
component is the major criteria in determining their 
acceptance or rejection. Stability studies were carried 
out as per ICH Q1A guidelines. During the stability 
studies, the product is exposed to normal conditions of 
temperature and humidity. The optimized Tadalafil 
formulations were subjected for stability studies. 
RESULTS AND DISCUSSION 
Preformulation Study: 
Preformulation testing is the first step in the rational 
development of dosage forms of a drug. It can be 
defined as an investigation of physical and chemical 
properties of drug substance, alone and when combined 
with excipients. The overall objective of preformulation 
testing is to generate information useful to the 
formulator in developing stable and bioavailable dosage 
forms, which can be mass-produced. Tadalafil is a white 
or almost white amorphous and odourless powder. 
Melting point of Tadalafil was found to be 298℃. It is 
soluble in methanol and 0.1 N HCL and practically 
insoluble in water.  
IR Spectroscopy: 
 The FT-IR spectrum of the obtained sample of drug was 
conducted and compare with the standard FT-IR spectra 
of the pure drug. 
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Figure 1: FTIR Spectrum of tadalafil  
 
Differential Scanning Calorimetry (DSC): 
Differential Scanning Calorimetry (DSC) was 
performed using differential scanning calorimeter 
(SW9.2, Mettler Star) equipped with a computerized 
data station on pure drug tadalafil to determine the 
melting point and exothermic and endothermic peaks. 
An empty standard aluminium pan was used as 
reference. DSC scans were recorded at heating rate of 
10°C/min in the temperature range30°-300°C and 40 
ml/min of nitrogen flow. 
 
 
                                                              Figure 2: DSC of tadalafil                   
Characterization of prepared SDs 
The prepared SD was subjected for solubility study and 
optimized ratio was evaluated for further 
characterization. 
Solubility Study:  
The prepared SD was subjected for solubility 
studies to evaluate the effect of carrier on the 
aqueous solubility of TDL were studied and results of 
phase solubility analysis are shown in Table.3. 
                 
                                                                          Table 3: Result of Phase solubility study 
Sr. No Formulation 
Code 
Drug Polymer Ratio Solubility(mg/ml) 
±S.D. 
Fold increase 
Insolubility (Fold) 
 1. 
 
 2. 
 
 3. 
 
4. 
      Drug 
 
       SD1 
 
       SD2 
 
       SD3 
 TDL 
 
 TDL 
 
 TDL 
 
TDL 
     ----- 
 
PLX 188 
 
PLX 188 
 
PLX 188 
  ----- 
 
1:0.5 
 
 1:1 
 
  1:2 
   0.250 
 
   0.567 
 
   0.385 
 
   0.128 
   1-fold 
 
  9.75-fold 
 
  6.10-fold 
 
3.90-fold 
Sisodiya et al                                                                                                     Journal of Drug Delivery & Therapeutics. 2018; 8(5):294-302           
ISSN: 2250-1177                                                                             [299]                                                                             CODEN (USA): JDDTAO 
Drug Content Estimation: 
The selected ratios were subjected to the 
determination of drug content. The drug content in 
the selected ratios was found to be in range of 92 to 
98%. Almost negligible loss of drug may have 
occurred probably because preparation of 
combinations was confined to the very small area of 
mortar.  
Production Yield: 
The production yield of solid dispersion prepared by 
solvent evaporation method was found to be 86.66%. 
Any loss in yield can be attributed to the product 
remaining adhered to the walls of the mortar which 
could not be retrieved the results of Percentage Yield. 
Table 4: Result of Percentage Yield 
Sr. No. Drug Polymer Ratio Percentage Yield 
 1. Tadalafil PLX 188 1:0.5 86.66 % 
2. Tadalafil PLX 188 1:1 70 % 
3. Tadalafil PLX 188 1:2 83.3% 
  
IR Spectroscopy: 
The FT-IR spectrum of the Solid dispersion was conducted and compare with the standard FT-IR spectra of the pure 
drug. 
 
Figure 3: FTIR Spectrum of SD 
 
Differential Scanning Calorimetry (DSC): 
The solid dispersion showed the melting point reduced 
to 303°C from 254 °C and 60 °C to 49°C and the 
intensity of the peak in pure drug is reduced. The sharp 
endothermic peak of pure drug was not observed in solid 
dispersion, which indicates that the Tadalafil was 
molecularly dispersed and in amorphous form. This 
change indicates that the dehydration of pure drug and 
change in the particle size giving more amorphous type 
of the product this may help in cleaving the solubility of 
drug. These shifting 0f peaks are due to the above 
experimental reason but not to interaction. 
 
 
Figure 4: DSC of SD 
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X-Ray Diffraction of SD: 
Diffraction spectra of solid dispersion prepared by 
solvent evaporation method are presented in Fig. 5 
respectively. The XRD of Tadalafil shows sharp peaks 
indicating that the drug is of crystalline nature. While 
that of solid dispersion shows blunt peaks indicating its 
amorphous nature. This proves the conversion of 
crystalline form of drug into amorphous form in solid 
dispersion. Thus, result of XRD support the findings of 
the DSC study. 
 
 
Figure 5: XRD of SD 
Evaluation of tablets: 
Precompressional evaluation  
Table 5: Precompressional evaluation 
Batch 
No. 
Bulk density 
(gm/cm
3
) 
Tapped density 
(gm/cm
3
) 
Compressibility 
index (%) 
Hausner’s ratio Angle of 
repose(ө) 
F1 0.399± 0.012 0.4545± 0.040 13± 0.109 1.15± 0.06 23.43± 0 
F2 0.3949±0.017 0.4690±0.003 15± 0.1063 1.18± 0.06 22.50± 0.19 
F3 0.3897±0.022 0.4413±0.007 11± 0.12 1.13± 0.03 23± 0.25 
F4 0.3949±0.017 0.4690±0.03 15± 0.18 1.18± 0.02 28.55± 0.65 
F5 0.4017±0.017 0.4545±0.040 11± 1.26 1.13± 0.1 25± 0.45 
F6 0.3949±0.017 0.4413±0.02 10± 0.108 1.11± 0.09 23.5± 0.29 
F7 0.3949±0.017 0.4690±0.03 15± 0.44 1.18± 0.007 29.55± 0.60 
F8 0.3846±0.001 0.4545±0.001 15± 1.3288 1.18± 0.01 23.5± 0.96 
F9 0.4055±0.002 0.4690±0.03 13± 0.9825 1.15± 0.04 28.5± 0.946 
 
The above results predict that, the Carr’s index is in 
range of 10-15% which is considered as Ecxellent 
compression property. Angle of repose less than 30
o
 
gives excellent flow property to the granules blend. 
Similarly, bulk density and tapped density value was 
found to be less than one. Hence have good flow 
property. All these results indicate that, the granules 
blend possess satisfactory flow and compressibility 
properties.
 
Post compressional evaluation: 
Table 6: Postcompressional evaluation 
Batch 
No. 
Thickness 
(mm) 
Hardness 
(kg/cm
2
) 
Friability (%) Weight   
variation (mg) 
Disintegration 
Time 
% CDR 
F1 4.47 ± 0.05 3.46 ± 0.09 1.010±0.045 245.65±0.076 1 min 32 sec 85.05 
F2 4.47 ± 0.03 2.50 ± 0.08 0.326±0.040 248 ± 0.36 1min 50 sec 79.65 
F3 4.50 ± 0.02 3.06 ±0.074 1.063±0.023 248.2 ± 0.47    1 min    89.1 
F4 4.34 ± 0.02 2.73 ±0.09 0.531±0.023 248 ± 0.047 1min 45 sec 94.8 
F5 4.48 ± 0.03 3.2 ± 0.06 1.291±0.046 249 ± 0.002    54 sec 92.2 
F6 4.49 ± 0.01 2.5 ± 0.05 0.326±0.046 248 ± 0.002    35 sec 98.6 
F7 4.47 ± 0.06 2.6 ± 0.06 0.266±0.061 249 ± 0.003 1min 20 sec 96.75 
F8 4.49 ± 0.03 3.06 ± 0.1 0.279±0.040 248 ± 0.004    45 sec 89.7 
F9 4.49 ± 0.02 2.6 ± 0.1 1.476±2.074 249 ± 0.031     57 sec 89.70 
 
All the tablet preparations were evaluated for various 
physical parameters before proceeding further. Tablet 
weights in all batches varied between 245-250 thickness 
between 4.47-4.50 and tablet hardness between 2.50-
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3.46. Thus, all the physical parameters of the manually 
compressed tablets were quite within control. The 
percentage friability, as depicted in Table was in the 
range of 0.265-1.476 to be well within approved range 
(<1%) which indicates the tablet had good mechanical 
resistance.
 
Dissolution rate study  
Table 7: Dissolution data of Tablets of Tadalafil 
 
Time 
(min) 
Formulation Batches 
F1 
(%) 
F2 
(%) 
F3 
(%) 
F4 
(%) 
F5 
(%) 
F6 
(%) 
F7 
(%) 
F8 
(%) 
F9 
(%) 
5 43.55 37.8 34.05 47.3 35.95 43.55 34.05 39.75 47.3 
10 53.05 51.15 39.75 51.15 49.25 53.05 45.45 53.05 53.05 
15 66.30 66.3 56.8 64.35 62.55 68.25 54.9 58.9 66.3 
20 72.00 73.80 70.15 75.8 69.75 77.60 66.3 72 75.8 
25 80.75 77.40 77.40 83.4 89.00 89.10 89.1 80.75 80.75 
   30 85.05 79.65 89.1 94.8 92.9 98.6 96.75 89.7 89.70 
 
 
Figure 6: Dissolution Profile of Tablet (F1-F9) 
 
Dissolution Kinetics:  
Release kinetics studies  
The dissolution kinetics of optimized batch was applied 
to various dissolution models such as Zero order, First 
order, Higuchi, Korsemayer- peppas. The best fitted 
model gives the highest R2 value and least slope value. 
Thus, zero order model fits best for the dissolution data 
of the optimized batch as it showed the highest value for 
R2. 
Table 8: Drug Release kinetics of optimized batch 
S. N. Models R
2 
Value 
1 
2 
Zero Order 
First Order 
0.9861 
0.9539 
3 
4 
Higuchi 
Korsemayer-peppas 
0.9608 
0.7825 
 
 
 
         Figure 7: Model Graph for Zero Order Kinetics 
CONCLUSION 
There is enhancement of the solubility rate if tadalafil by 
solid dispersion with Poloxamer 188 prepared by 
solvent evaporation method. The drug was characterized 
for its organoleptic properties and the results obtained 
collaborated with literature. The IR spectra and DSC 
Thermogram also confirmed the drug’s identity and 
purity.  The compatibility studies of the drug and 
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polymers showed that there was no incompatibility 
between them. Melting point of tadalafil was found to 
be 298
0
 C which was within the literature range 301-
302
0
C.In- vitro release was studied using USP 
dissolution apparatus at a constant temperature of 37 ± 
0.5
0
C at RPM 50 for a period of 30 min shows increase 
in drug release. Wet granulation method showed that, 
the desirable flow properties for the compression into 
tablets. Tablets were prepared using wet granulation 
method resulted into simple, cheap, more suitable 
method for the manufacturing immediate release dosage 
form.
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